Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk - 26/03/24
Highlights |
• | This systematic review including133 studies covered the global prevalence of almost all EHCs in PBC. |
• | The prevalence of various EHCs in PBC patients greatly varies from 0 to 28.6 %. |
• | PBC may be associated with increased prevalence of several EHCs. |
• | This study suggested that prompt recognizing EHCs are of great importance for timely and precise diagnosis of PBC. |
Abstract |
Background and Aim |
Many studies reported the prevalence of extrahepatic conditions (EHC) of primary biliary cholangitis (PBC), but the great heterogeneity existed across different studies. Therefore, we conducted the systematic review and meta-analyses to determine EHC prevalence and association with PBC.
Methods |
We searched PUBMED and included observational, cross-sectional and case-controlled studies. A random or fixed effects model was used to estimate the pooled prevalence and odd ratio (OR) as appropriate.
Results |
Of 5370 identified publications, 129 publications with 133 studies met the inclusion criteria. Sjögren's syndrome had the highest prevalence (21.4 % vs. 3 % in non-PBC individuals), followed by Raynaud's syndrome (12.3 % vs. 1 %), rheumatoid arthritis-like arthritis (5 % vs. 3 %), systemic sclerosis (3.7 % vs. 0 %) and systemic lupus erythematosus (2 % vs. 0 %). The prevalence of overall thyroid diseases (11.3 %), autoimmune thyroid diseases (9.9 %), osteoporosis (21.1 %), celiac disease (1 %) and chronic bronchitis (4.6 %) was also increased among PBC patients.
Conclusion |
This is the first exhaustive study on the old theme about EHC of PBC. Given increased prevalence of many EHCs in PBC patients, promptly recognizing these EHCs are of great importance for timely and precise diagnosis of PBC.
Le texte complet de cet article est disponible en PDF.Key words : Primary biliary cholangitis, Extrahepatic conditions, Prevalence
List of Abbreviations : PBC, UDCA, EHCs, OP, CeD, TDs, SjS, PRISMA, SLE, RA, PM, DMs, SSc, RS, M/UCTD, AS, APS, HT, GD, IBD, MS, MG, TIA, CHD, CAD, CBD, HF, ILD, PAH, MeS, DM, ITP, OR, CI, T2DM, CKD, RTA, MN, PIF, IPF, BOOP, COPD
Plan
Vol 48 - N° 5
Article 102321- mai 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?